MOE Key Laboratory of Protein Sciences, Laboratory of Molecular Pharmacology and Pharmaceutical Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China.
Sci Rep. 2017 Feb 9;7:41712. doi: 10.1038/srep41712.
After being studied for approximately a century, berberine (BBR) has been found to act on various targets and pathways. A great challenge in the pharmacological analysis of BBR at present is to identify which target(s) plays a decisive role. In the study described herein, a rescue experiment was designed to show the important role of mitochondria in BBR activity. A toxic dose of BBR was applied to inhibit cell proliferation and mitochondrial activity, then α-ketobutyrate (AKB), an analogue of pyruvate that serves only as an electron receptor of NADH, was proven to partially restore cell proliferation. However, mitochondrial morphology damage and TCA cycle suppression were not recovered by AKB. As the AKB just help to regenerate NAD+, which is make up for part function of mitochondrial, the recovered cell proliferation stands for the contribution of mitochondria to the activity of BBR. Our results also indicate that BBR suppresses tumour growth and reduces energy charge and mitochondrial DNA (mtDNA) copy number in a HepG2 xenograft model. In summary, our study suggests that mitochondria play an important role in BBR activity regarding tumour cell proliferation and metabolism.
经过大约一个世纪的研究,小檗碱(BBR)已被发现作用于多种靶点和途径。目前,BBR 药理学分析的一个巨大挑战是确定哪个(些)靶点起决定性作用。在本文所述的研究中,设计了一项挽救实验以显示线粒体在 BBR 活性中的重要作用。用有毒剂量的 BBR 抑制细胞增殖和线粒体活性,然后证明 α-酮戊二酸(AKB),丙酮酸的类似物,仅作为 NADH 的电子受体,部分恢复细胞增殖。然而,AKB 并不能恢复线粒体形态损伤和 TCA 循环抑制。由于 AKB 仅有助于再生 NAD +,这弥补了线粒体的部分功能,恢复的细胞增殖代表了线粒体对 BBR 活性的贡献。我们的结果还表明,BBR 在 HepG2 异种移植模型中抑制肿瘤生长并降低能量电荷和线粒体 DNA(mtDNA)拷贝数。总之,我们的研究表明,线粒体在 BBR 对肿瘤细胞增殖和代谢的活性中起重要作用。